| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.14 | 0.3 |